Integration of network pharmacology, structure-based pharmacophore modeling, DFT, molecular docking, and molecular dynamics simulations to identify multi-target small molecule inhibitors against Alzheimer’s disease
- 19 September 2026
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- p. 1-35
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Monoamine Oxidase‐B (MAO‐B) Identifies Neurotoxic Reactive Astrocytes in Alzheimer's Disease and Related DementiasAlzheimer's & Dementia, 2025
- Interplay between PI3k/AKT signaling and caspase pathway in Alzheimer disease: mechanism and therapeutic implicationsInflammopharmacology, 2025
- Resveratrol: A Natural Compound Targeting the PI3K/Akt/mTOR Pathway in Neurological DiseasesMolecular Neurobiology, 2024
- 2024 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2024
- Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer’s disease and related dementiasActa Neuropathologica, 2024
- An Allosteric Inhibitory Potential of Triterpenes from Combretum racemosum on the Structural and Functional Dynamics of Plasmodium falciparum Lactate Dehydrogenase Binding LandscapeChemistry & Biodiversity, 2022
- Small-Molecule Library Screening by Docking with PyRx2014
- Biological Network Exploration with Cytoscape 3Current Protocols in Bioinformatics, 2014
- CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR dataJournal of Computational Chemistry, 2013
- Improved side‐chain torsion potentials for the Amber ff99SB protein force fieldProteins: Structure, Function, and Bioinformatics, 2010